Prognostic and Therapeutic Significance of COP9 Signalosome Subunit CSN5 in Prostate Cancer

Deregulation of CSN5, a putative androgen receptor (AR), could affect diverse cellular functions that contribute to tumor development. Inhibition of CSN5 repressed metabolic pathways, including oxidative phosphorylation and glycolysis in AR-negative prostate cancer cells.